Table 2 Comparisons of initial laboratory findings between patients with PTB and CAP.

From: The utility of delta neutrophil index in differentiation of pulmonary tuberculosis from community acquired pneumonia

Characteristics

PTB (n = 62)

CAP (n = 215)

P-value

Inflammatory markers

   WBC count (/μL)

6625 (5528–9065)

9190 (6540–13400)

<0.001

   DNI (%)

0 (0–0.2)

1.6 (0.7–2.9)

<0.001

   CRP (mg/L)

21.7 (4.2–75.6)

81.3 (34.8–133.7)

<0.001

Microbiological results

   Mycobacterium tuberculosis

46 (74)*

NA

   Non-mycobacterial agents

10 (16)

144 (67)

<0.001

   S. pneumoniae

3/10

25/144

 

   H. influenzae

2/10

17/144

 

   M. pneumoniae

4/144

 

   S. pneumoniae + H. influenzae

5/10

47/144

 

   S. pneumoniae + M. pneumoniae

15/144

 

   H. influenza + M. pneumoniae

2/144

 

   S. pneumoniae + H. influenza + M. pneumoniae

17/144

 

   K. pneumoniae

7/144

 

   P. aeruginosa

3/144

 

   S. aureus

3/144

 

   C. pneumoniae

1/144

 

   M. catarrhalis

1/144

 

   B. pertussis

1/144

 

   L. pneumophila

1/144

 

Viral agents

3/48 (6)

35/130 (27)

 

   Rhinovirus

1/3

9/35

 

   Metapneumovirus

9/35

 

   Influenza A or B

2/3

7/35

 

   Parainfluenza virus

3/35

 

   Coronavirus

3/35

 

   Respiratory syncytial virus

3/35

 

Influenza A + Respiratory syncytial virus

1/35

 
  1. Data are shown as median (interquartile range) or number (%). CAP community acquired pneumonia; CRP C-reactive protein; DNI delta neutrophil index; PTB pulmonary tuberculosis; WBC white blood cell count; not applicable; negative. *Twelve patients were diagnosed with tuberculous pleurisy with (10/12) or without (2/12) suspected pulmonary lesion and 4 patients were compatible with clinical active PTB.